Clinical Trial Update: Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma) [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating radiofrequency ablation for hepatocellular carcinoma (liver cancer) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: WITHDRAWN